Biomarker-driven protocol model broadens lung cancer trial access for some underrepresented groups
by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainAs compared to conventional, stand-alone clinical trials in advanced non-small cell lung cancer (NSCLC), the biomarker-driven Lung Cance
Updated on: January 04,2024
8
Biomarker-driven protocol model broadens lung cancer trial access for some underrepresented groups
by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainAs compared to conventional, stand-alone clinical trials in advanced non-small cell lung cancer (NSCLC), the biomarker-driven Lung Cance
Updated on:January 04,2024
8
